We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Gastric Bypass Surgery Offers Long-Term Resolution of Diabetes

By HospiMedica International staff writers
Posted on 06 Jul 2009
A new study has found that bariatric surgery is one of the most effective long-term treatments for morbidly obese patients with type 2 diabetes. More...


Researchers at the Virginia Commonwealth University (VCU; Richmond, USA) conducted a retrospective analysis of 177 people with morbid obesity and type 2 diabetes that underwent gastric bypass surgery between 1993 and 2003. The researchers divided patients into three categories, based on their diabetes treatment prior to surgery: insulin dependent (59); oral medications (83); or diet and lifestyle changes only (35). The patients were followed from 5 to 16 years. The researchers found that the patients who had a recurrence of diabetes regained about 10% more of their excess weight than those with no recurrence. Those most likely to experience a recurrence of diabetes regained the most weight or had a more severe insulin-dependent form of diabetes prior to surgery; on average, patients who remain free of diabetes had excess weight loss of about 73%, while diabetes returned in those that had 66% or less excess weight loss. More than 75% of patients who were controlling their diabetes with dietary and lifestyle management and more than 65% who were using oral medications before surgery continued to be diabetes-free after gastric bypass surgery. About 70% of insulin-dependent patients had a recurrence of diabetes independent of weight loss or gain, and 40% of those who regained about 20% of the weight also experienced a return of the disease. In all, nearly 90% of morbidly obese patients with type 2 diabetes experienced diabetes resolution within the first year of gastric bypass surgery, and about 60% remained diabetes-free 5 to 16 years later.

The study was presented at the 26th annual meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS), held during June 2009 in Grapevine (TX, USA).

"The severity of the diabetes at the time of surgery and the regain of excess weight loss long-term seem to be the primary determinants of long-term diabetes resolution after gastric bypass surgery,” said study presenter and coauthor Professor James Maher, M.D. "This study suggests that people with Type 2 diabetes and morbid obesity who get surgery before becoming insulin-dependent have the greatest chance for complete resolution and avoiding the progression of diabetes.”

People who are morbidly obese have a body mass index (BMI) score of 40 or more, or a BMI of 35 or more with an obesity-related disease, such as type 2 diabetes, heart disease, or sleep apnea. The American Diabetes Association (ADA) recently recommended that bariatric surgery be considered for adults with a BMI score of over 35 and Type 2 diabetes, especially if diabetes is difficult to control under their current therapy. The most common methods of bariatric surgery are laparoscopic gastric bypass and laparoscopic adjustable gastric banding (LAGB).

Related Links:

Virginia Commonwealth University




Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Powered Surgical Stapler
ECHELON 3000 Stapler
New
Enteral Feeding Pump
Instilar 1420
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The principle of needle-free injection based on the reflection of shock waves through microbubble dynamics (Photo courtesy of Yibo Ma/Kyushu University)

Novel Needle-Free Reagent Injection Method to Reduce Spread of Infectious Diseases

Currently, drug administration for disease treatment and prevention commonly uses injectors with metal needles. However, as the needle directly contacts the patient’s mucus and blood, the use of different... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.